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ABSTRACT
Objectives. To investigate the preva-
lence of ultrasound (US) detectable ab-
normalities in the hip joints of patients 
with osteoarthritis (OA) and correlate 
them with clinical findings and meas-
ures of disease severity. 
Methods. Consecutive patients with 
hip OA were investigated by clinical 
and US examinations. Bilateral US of 
the hip joints was performed by using a 
Logiq9 machine, equipped with a multi-
frequency linear probe, operating at 9 
MHz; in addition, power Doppler (PD) 
was applied (frequency 7.5 MHz; PRF 
750 Hz). Clinical evaluation included 
the registration of demographic data, 
disease duration, current and previ-
ous joint pain and Lequesne index. US 
study included the assessment of both 
inflammatory and structural abnor-
malities at the level of hip joint (joint 
effusion, synovial hypertrophy, local 
pathologic vascularisation at PD, os-
teophytes) and periarticular soft tis-
sues (ilio-psoas bursitis, trochanteric 
bursitis, iliopsoas tendinopathy, glu-
teus medius tendinopathy and gluteus 
minimus tendinopathy).  
Results. One hundred and fifty hips of 
75 patients were studied. Clinical ex-
amination demonstrated the presence of 
current hip pain in 80% of patients and 
previous hip pain in 85.7% of cases. The 
mean Lequesne Index was 11.9±4.9. US 
detected effusion in 50% of the joints, 
synovial hypertrophy in 41.3%, PD sig-
nal in 0.7%, osteophytes in 77.3%; at 
periarticular level, trochanteric bursitis 
was found in 24.7% of patients, gluteus 
tendinopathy in 22.7%, iliopsoas tendi-
nopathy in 7.3% and finally iliopsoas 
bursitis in 1.3%. The presence of cur-
rent and previous hip pain significantly 
correlated with the presence of effusion 
(p=0.01); age and disease duration 
significantly correlated with the pres-
ence of osteophytes (p=0.01). Various 
US-detected abnormalities were found 
also in asymptomatic patients. Statis-
tically significant differences between 
the 2 subgroups of symptomatic and 
asymptomatic patients were registered 
for effusion (p=0.003).
Conclusions. In hip OA, US is a useful 
imaging tool for analysing both inflam-
matory and structural damage lesions 
as well as for differentiating the in-
volvement of joint structures and peri-
articular soft tissues. In addition, US 
was able to detect a wide set of abnor-
malities even in asymptomatic patients, 
confirming that it is more sensitive than 
clinical examination in detecting mus-
culoskeletal involvement.
Introduction
Osteoarthritis (OA) is the most com-
mon rheumatic disease, affecting most 
synovial joints. It represents a com-
plex pathologic process involving all 
joint tissues with an imbalance of lo-
cal turnover and repair and consequent 
global joint failure (1-4). Predominant 
involvement of the hyaline cartilage 
is present and is associated with bone 
and joint capsule abnormalities. In ad-
dition, episodic synovitis with char-
acteristic non-destructive and non-ag-
gressive features frequently occurs and 
often contributes to the appearance and 
worsening of symptoms (2, 3). Usually, 
OA appears and progressively wors-
ens with the advance of old age, even 
though it may sometimes occur earlier 
in life. Clinically, it is characterised by 
use-related pain, stiffness, deformity 
and reduced joint motion that result in 
disability and work impairment (2, 4). 
The hip joint is frequently involved in 
OA, with very different disease patterns 
and variable natural history. Hip OA is 
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traditionally imaged using conventional 
radiographs that demonstrate the pres-
ence of characteristic structural lesions 
but have clear limitations in visualising 
soft tissue abnormalities (1, 2). Con-
trast-enhanced MRI might be a useful 
technique for diagnosis and staging of 
hip OA since early disease (5). How-
ever its routine use is burdened by high 
costs and limited equipment availabil-
ity. Ultrasound (US) is a sensitive and 
bedside imaging tool for the assessment 
of most joint abnormalities in rheumatic 
diseases and its emerging role has been 
highlighted also in recently published 
classification criteria for specific disor-
ders (6-12). In the last few years there 
has been an increasing interest on the 
part of investigators in the application 
of US in OA and a more widespread 
use of this tool for assessing different 
changes in the osteoarthritic joints has 
been registered (2). In addition to its 
emerging applications in clinical prac-
tice, many recently published studies 
demonstrate a new interest also of re-
search in this field. In OA, US is able to 
detect a wide set of abnormalities both 
at joint level and in the periarticular soft 
tissues. However, its role in assessing 
hip OA is still to be defined and the ma-
jority of reports present in the literature 
in the field have been mainly focused 
on the use of US for guiding hip joint 
injections (13, 14). 
The aims of the present study were to 
investigate the prevalence of US-de-
tectable abnormalities in the hip joints 
of patients with OA and to correlate 
them with clinical findings and meas-
ures of disease severity.
Patients and methods
Consecutive patients with hip OA were 
included in the present multicentre 
study that was conducted in four Ital-
ian units of rheumatology (Sapienza 
Università di Roma, Università Po-
litecnica delle Marche, Università di 
Pisa and Università di Pavia). All the 
patients met the American College of 
Rheumatology criteria for hip OA and 
were enrolled independently of disease 
duration and severity of clinical signs 
of hip involvement (15). In all subjects 
clinical assessment and US examina-
tion were performed for both hips. 
Prior to US evaluation, an expert rheu-
matologist registered demographic data 
and disease duration. In addition, the 
presence/absence of previous and/or 
current hip joint pain was recorded. 
Moreover, in all cases the Lequesne in-
dex was used to assess the severity for 
OA of the hip (16).
The presence of any other rheumatic 
disease and history of either severe 
trauma or surgery of the hip were the 
criteria for exclusion from the study.
The study was conducted according to 
the Declaration of Helsinki and local 
regulations, and informed consent was 
obtained from all the patients.
  
US scanning technique
Prior to patient enrolment, the US ex-
amination methodology was clarified 
among sonographers and a consensus 
was obtained on scanning protocol 
and image interpretation. In the 4 units 
participating in the study, US examina-
tion was separately and independently 
performed by a single ultrasonographer 
who was a rheumatologist experienced 
in musculoskeletal US and was blinded 
to the clinical findings.
Bilateral US of the hip joints was per-
formed on the same day as the clinical 
evaluation by using a Logiq9 machine 
(General Electrics Medical Systems, 
Milwaukee, WI), equipped with a mul-
ti-frequency linear probe, operating at 
9 MHz. At the beginning of each scan-
ning session, the focus was positioned 
at the level of the region of interest. In 
addition, power Doppler (PD) was ap-
plied (frequency 7.5 MHz; PRF 750 
Hz). The colour box was positioned at 
the level of the joint area to be exam-
ined, enlarging the box to the upper part 
of the image. Colour gain was adjusted 
just below the degree that caused the 
appearance of noise artefacts (17). 
The patients were examined while ly-
ing supine, with the hips in neutral po-
sition and the heels together (18-20). A 
standardised anterior longitudinal scan 
(oblique sagittal plane along the axis 
of the femoral neck) was performed 
in order to visualise the bony profile 
of the femoral head and neck, the joint 
capsule as well as the iliopsoas tendon 
and bursa (18). The trochanteric area 
for the study of gluteus tendons and 
bursa was assessed by performing lon-
gitudinal and transverse scans with the 
patients on the opposite lateral posi-
tion. US examinations were carried out 
after an abundant amount of gel was 
applied to the skin to provide an appro-
priate acoustic interface; particularly 
for the trochanteric area, attention was 
made to avoid applying probe pressure 
on the anatomical structures under ex-
amination. During the same scanning 
session, US was initially performed 
in B-mode modality with the aim of 
detecting morphological changes and 
immediately afterwards by using PD 
technique searching for local abnormal 
vascularisation. According to com-
monly used international definitions of 
pathological findings and including the 
assessment of both inflammatory and 
structural abnormalities, the following 
changes were registered (18, 20-22): 
a) Hip joint abnormalities: joint effu-
sion (JE), joint synovial hypertrophy 
(SH), local pathologic vascularisa-
tion at PD, osteophytes;
b) Periarticular soft tissues abnormali-
ties: ilio-psoas bursitis, trochanteric 
bursitis, iliopsoas tendinopathy, glu-
teus medius tendinopathy and glu-
teus minimus tendinopathy.
Each pathological US finding was con-
firmed in two perpendicular planes. All 
US-detected lesions were registered 
according to a dichotomous (presence/
absence) score. 
Statistical analysis 
The statistical calculations were made 
using Statistical Package for Social 
Sciences 13.0 (SPSS, Chicago, IL, 
USA) and GraphPad 5.0 (La Jolla, CA, 
USA). 
Normally distributed variables were 
summarised using the mean±SD, and 
non-normally distributed variables by 
the median and range. Percentages 
were used for the prevalence of the 
alterations. Wilcoxon’s matched pairs 
test and paired t-test were performed. 
Univariate comparisons between nomi-
nal variables were calculated using chi-
square (χ2) test or Fisher’s exact test. 
Two-tailed p-values were reported; p-
values less than or equal to 0.05 were 
considered significant.
654
IMAGING Hip ultrasound in OA / A. Iagnocco et al.
Results 
Seventy-five patients (29 males and 46 
females) were studied. A total of 150 
hip joints were examined both by clini-
cal examination and US assessment. 
Patients’ demographic and clinical 
characteristics are reported in Table I.
The presence of current hip pain was 
registered in the majority of patients 
(80%) and was principally localised at 
the left hip (66.6%) with respect to the 
contralateral side (61.2%). A history 
of hip pain during previous years was 
referred by 85.7% of patients and was 
localised at the level of the right hip 
in 69.4% of cases and at the left hip in 
67.3% of joints. 
The mean Lequesne Index was 
11.9±4.9. 
The results of US-detected abnormali-
ties at the level of joint structures and 
periarticular soft tissues are reported in 
Table II.  
JE was the most frequent finding, and 
was detected in 46/75 patients (61.3%) 
corresponding to 50% of evaluated hip 
joints (Fig. 1a-b). The right and left 
hips were similarly affected (50.7% vs. 
49.3%). 
Interestingly, SH was identified in 
31/75 subjects (41.3%) and 34.6% of 
joints. Also in this case, the right and 
left hips were similarly involved (36% 
vs. 33.3%).
PD signal was detected only in 1 joint 
(0.7%) of 1 patient (1.3%). 
Osteophytes were imaged in the major-
ity of cases (81% of patients; 77.3% of 
joints; right vs. left hip 80% vs. 74.6%) 
(Fig. 1b-c).
US assessment of periarticular soft 
tissues demonstrated that trochanteric 
bursitis was the most frequent finding 
(45.3% of patients; 24.7% of sites), 
followed by gluteus medius/minimus 
tendinopathy (28% of subjects; 22.7% 
of sites) (Fig. 1d), iliopsoas tendinopa-
thy (10.6% of patients; 7.3% of sites) 
and, finally, iliopsoas bursitis (2.6% of 
subjects; 1.3% of sites).
The analysis of the correlations be-
tween clinical features and US findings 
at the level of the hip joint demon-
strated that the presence of current hip 
pain as well as a history of hip pain sig-
nificantly correlated with the presence 
of JE (p=0.01) (Table III). In addition, 
both mean age and mean disease dura-
tion significantly correlated with the 
presence of osteophytes (p=0.01) (Ta-
ble III). On the contrary, no differences 
were found between subjects with or 
without US synovial hypertrophy in 
terms of age, disease duration, previ-
ous or present hip pain and, finally, the 
Lequesne index from patients with nor-
mal US findings. 
Concerning the relationships between 
clinical findings and US abnormalities 
detected at the level of periarticular soft 
tissues, patients with US changes did 
not differ significantly in terms of all 
clinical variables examined (Table IV). 
Patients were then divided into 2 sub-
groups, according to the presence or 
absence of symptoms. US-detected fea-
tures in asymptomatic patients as well 
as in symptomatic subjects and the dif-
ferences between the 2 subgroups are 
reported in Table V. Fifteen subjects 
did not refer any pain in both hips at 
the time of enrolment. However, 20% 
of them had JE. Similarly, in 20% of 
asymptomatic cases US detected SH. 
In addition, 26.6% of them had signs 
of trochanteric bursitis. Finally, glu-
teus medius or minimus tendinopathy 
was demonstrated in 9.3% of asympto-
matic cases. All symptomatic patients 
had one or more signs of pathological 
involvement at US assessment, being 
osteophytes the most frequent finding 
(76.6%), followed by JE (71.6%), tro-
chanteric bursitis (50%), SH (46.6%), 
gluteus medius or minimus tendinopa-
thy (23.3%); finally, iliopsoas tendino-
pathy and PD signal were rarely found 
(13.3% and 1.6%, respectively).
Statistically significant differences be-
tween the 2 subgroups of patients were 
registered in terms of JE which was 
present in 3 asymptomatic patients vs.  
43 subjects with symptoms (p=0.003).  
No significant differences were found 
in the 2 subgroups, concerning the val-
ues of the Lequesne Index (subgroup 
1= 0–10; subgroup 2 = 1–20).
Discussion
Hip OA is a common disease that af-
fects a large part of the elderly popula-
tion. US has demonstrated its ability to 
play a relevant role in the detection of 
many alterations at the level of differ-
ent synovial joints in OA. However, its 
applications so far, particularly in pa-
tients with hip involvement, have been 
Table I. Patients demographic and clinical characteristics.
 Patients (n=75) Joints (n=150)
 
    Right hip Left hip
    (n=75)  (n=75)
M/F 29/46 – –
Mean age±SD (years) 71.7 ± 7.5 – –
Mean disease duration±SD (months) 70.8 ± 72.2 – –
Clinical evaluation
Previous hip pain (n/%) 64 (85.7) 52 (69.4) 50 (67.3)
Current hip pain (n/%) 60 (80) 46 (61.2) 50 (66.6)
Lequesne index (mean±SD) 11.9 ± 4.9 – –
Table II. US-detected abnormalities  at the level of the hip joint and periarticular soft tissues.
US-detected abnormalities Patients Joints Right hip Left hip
 (n=75) (n=150) (n=75) (n=75)
Hip joint    
Joint effusion (n/%) 46 (61.3) 75 (50) 38 (50.7) 37 (49.3)
Synovial hypertrophy (n/%) 31 (41.3) 52 (34.6) 27 (36) 25 (33.3)
Power Doppler signal (n/%) 1 (1.3) 1 (0.7) 1 (1.3) 0
Osteophytes (n/%) 61 (81.3) 116 (77.3) 60 (80) 56 (74.6)
Periarticular soft tissues    
Iliopsoas bursitis (n/%) 2 (2.6) 2 (1.3) 1 (1.3) 1 (1.3)
Trochanteric bursitis (n/%) 34 (45.3) 37 (24.7) 14 (18.7) 23 (30.6)
Iliopsoas tendinopathy (n/%) 8 (10.6) 11 (7.3) 6 (8.0) 3 (4.0)
Gluteus medius / minimus 21 (28.0) 34 (22.7) 14 (18.6) 20 (26.6) 
    tendinopathy (n/%) 
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substantially focused on the execution 
of US-guided intra-articular injections 
(13, 14, 23-27). This aspect resembles 
other diseases, in which very few re-
ports exist in the literature about the 
US assessment of the hip joint, even 
though an increasing number of studies 
have been developed about the evalua-
tion of other synovial joints (28-31). 
As far as we know, for the first time the 
present study, focused on the investi-
gation of the prevalence of different 
US-detectable abnormalities in patients 
with hip OA and on their correlations 
with clinical findings and measures of 
disease severity, demonstrated that a 
wide range of changes may be present 
at hip level. In addition, the involve-
ment of both joint structures and peri-
articular soft tissues was shown with 
findings that were related to inflam-
mation as well as to structural lesions. 
Particularly, in terms of inflammatory 
abnormalities, two of the components 
of synovitis (i.e. JE and SH) were 
frequently detected, since they were 
present in the most of the joints. Con-
versely, PD signal was a very rare find-
ing that was shown only in a single hip 
joint of 1 patient. This last result is in 
line with the results of other studies as-
sessing the hip joints in patients with 
different rheumatic diseases and can be 
interpreted with the reduced sensitivity 
of US equipment in the assessment of 
deep areas respect to superficial joint 
structures (28-30). Even though OA is 
predominantly characterised by degen-
Fig. 1. Ultrasound of the hip in osteoarthritis. a. longitudinal anterior scan. Image representative of 
joint effusion (*). b. longitudinal anterior scan. Presence of joint effusion (*) and an osteophyte (è).    
c. longitudinal anterior scan. Marginal osteophytes (è) imaged at the level of the femoral and aceta-
bolar aspects of the joint d. Longitudinal lateral scan. Gluteus medius and minumus tendinopathy 
(dotted line) with evidence of loss of the tendon’s fibrillar pattern, hypoechogenicity and calcifications. 
F: femur; A: acetabulum; T: great trochanter.
Table IV. Correlations between clinical features and US findings at the level of periarticular soft tissues.
 Trochanteric bursitis Iliopsoas tendinopathy Gluteus tendinopathy
 
 Present Absent p-value  Present Absent p-value  Present Absent p-value 
Mean age±SD 71.0 ± 4.9 72.3 ± 9.1 NS 73.2 ± 3.9 71.6 ± 7.8 NS 72.1 ± 9.2 71.6 ± 6.9 NS
   (years) 
Mean disease duration±SD 71.4 ± 65.4 70.3 ± 78.6 NS 43.2 ± 16.1 73.9 ± 75.5 NS 76.3 ± 99.3 68.6 ± 59.8 NS
   (months) 
Previous hip pain (%) 86.4% 85.2% NS 80% 86.4% NS 85.7% 85.7% NS
Current hip pian (%) 86.4% 74.1% NS 80% 77.2% NS 64.3% 85.7% 0.01
Mean Lequesne Index±SD 12.5 ± 5.7 11.7 ± 4.1 NS 16.5 ± 1.9 11.3 ± 4.8 NS 12.3 ± 4.2 11.6 ± 5.4 NS
Iliopsoas bursitis was not included because it was present only in 2 cases.
Table III. Correlations between clinical features and US findings at the level of the hip joint.
 
 Joint effusion Synovial hypertrophy Osteophytes
 
 Present Absent p-value  Present Absent p-value  Present Absent p-value 
Mean age±SD 71.3 ± 6.1 72.3 ± 9.4 NS 71.5 ± 5.6 71.8 ± 8.6 NS 72.8 ± 7.6 66 ± 3.7 0.01
(years) 
Mean disease duration±SD 60 ± 46.8 97.8 ± 99.4 NS 67.9 ± 51.2 72.8 ± 84.6 NS 79.2 ± 76.7 36.2 ± 44.8 0.01
(months) 
Previous hip pain (%) 93.3% 73.7% 0.001 90% 82.7% NS 82.5% 100% NS
Current hip pain (%) 93.3% 57.9% 0.001 90% 72.4% NS 82.5% 100% NS
Mean Lequesne Index±SD 12.6 ± 5.3 11.1 ± 4.3 NS 12.7 ± 5.6 11.2 ± 4.2 NS 11.2 ± 5.0 10.3 ± 5.2 NS
PD signal was not included because it was present only in 1 joint of a single patient.
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erative findings which involve mostly 
the hyaline cartilage with associated 
bone and joint capsule abnormalities, 
synovitis may occur during the disease 
course and it has the characteristic non-
destructive and non-aggressive fea-
tures. It has been demonstrated that US 
is a sensitive tool for imaging synovitis 
and represents a valuable modality for 
assessing patients with inflammatory 
joint involvement. However, at hip joint 
level the US detection of Doppler sig-
nal within the synovial inflamed tissue 
is very difficult, in the great majority of 
cases, due to some technical limitations 
that influence the sensitivity of US (17, 
18). On the contrary, JE and SH which 
represent the other 2 components of 
synovitis are easily detected at hip joint 
level where US can, therefore, be con-
sidered a useful tool for demonstrating 
these particular findings. This aspect 
may have relevant implications, par-
ticularly when considering the difficult 
detection of hip synovitis by physical 
examination, due to the deep anatomic 
location of that joint. Thus, the use of 
US when evaluating patients with hip 
OA may have a relevant role and can 
be considered as an integral part of the 
joint assessment, to be combined with 
physical examination as a complemen-
tary tool.
In addition, when synovitis appears in 
OA, it usually contributes to the ap-
pearance and worsening of symptoms. 
Interestingly, in the present study, the 
presence of current hip pain as well as 
a history of previous hip pain correlated 
with the evidence of JE by US. JE is a 
fundamental component of joint inflam-
mation in hip OA and is also a relevant 
indicator of joint burden. This latter 
finding support the validity of US hip 
assessment in hip OA, when consider-
ing symptoms as the reference method.
As expected, osteophytes were detect-
ed in a large part of the assessed joints 
and, moreover, their presence signifi-
cantly correlated both with age and 
disease duration. These findings are in 
line with the complex pathologic proc-
ess of OA which is characterised by a 
wide set of abnormalities that include 
also bone involvement with osteophyte 
formation. All these structural lesions 
appear early during the disease course 
and progressively worsen with the ad-
vance of disease duration as well as 
with increasing of age.
In our study, periarticular soft tissue ab-
normalities were a frequent finding, par-
ticularly in terms of involvement of the 
trochanteric area, with US evidence of 
trochanteric bursitis as well as gluteus 
medius and minimus tendinopathy. Even 
though OA is a disease which charac-
teristically affects joint structures, these 
findings can be explained by the pres-
ence of mechanical abnormalities due to 
the complex joint osteoarthritic patho-
logical process. Mechanical imbalance, 
indeed, may cause secondary alterations 
of local periarticular structures, par-
ticularly at the level of the lateral hip. 
Trochanteric involvement is a frequent 
finding in patients with hip pain and 
loco-regional pathology, but has never 
been reported to be related to hip OA. 
Applied in this clinical setting, the pres-
ence of US-detected pathology at the 
level of trochanteric bursa and gluteus 
tendons could be either a non-specific 
picture or a particular finding that might 
be due to consequences of mechanical 
abnormalities due to joint disease that 
lead to difficult or abnormal gait. 
This particular aspect can also explain 
the lack of correlations between US 
abnormalities detected at the level of 
periarticular soft tissues and all clini-
cal variables examined, both in terms 
of patient’s characteristic and local 
symptoms.
Interestingly, when patients were sub-
grouped according to the presence of 
current hip pain, pathologic findings 
were detected also in asymptomatic 
joints, without any clinical evidence of 
inflammatory involvement. Except for 
the presence of JE that resulted to be 
significantly more frequent in the group 
of symptomatic with respect to asymp-
tomatic patients, all the other findings 
were similarly detected in both sub-
groups. This feature confirms the re-
sults obtained by previous studies that 
have underlined the higher sensitivity 
of US respect to clinical examination 
particularly in the detection of joint in-
flammation, and the capability of US of 
detecting a wide set of abnormalities, 
including subclinical synovitis (32-39). 
Interestingly, in addition to synovial 
involvement, osteophytes were demon-
strated by US in all asymptomatic cas-
es. This finding confirms that structural 
bony cortex lesions are an integral part 
of the complex pathology that develop 
in OA and that they can be present in-
dependently of joint pain.
This study carries a relevant limita-
tion represented by the lack of data in 
terms of cartilage involvement. OA is, 
indeed, a pathologic process character-
ised by predominant involvement of the 
hyaline cartilage. It would be therefore 
of interest to investigate the prevalence 
of cartilage abnormalities and its rela-
tionship both with clinical features and 
measures of disease severity. A further 
linitation of this study is represented by 
the assesssment of US findings in terms 
of presence/absence. However, for hip 
US, the relatively limited acoustic win-
dow available to the US beam makes 
detailed examination of hyaline carti-
lage impossible, since the sonographic 
visualisation is limited to a small por-
tion that is, in addition, the most periph-
eral part of cartilage which is outside 
Table V.  US-detected features in asymptomatic patients respect to symptomatic patients.
 Asymptomatic Symptomatic p-value 
 patients patients
 (n=15; 20%) (n=60; 80%) 
Hip joint   
Joint effusion (n/%) 3 (20.0) 43 (71.6) 0.0003
Synovial hypertrophy (n/%) 3 (20.0) 28 (46.6) NS
Power Doppler signal (n/%) 0  1 (1.6) NS
Osteophytes (n/%) 15 (100) 46 (76.6) NS
Periarticular soft tissues   
Iliopsoas bursitis (n/%) 0  2 (3.3) NS
Trochanteric bursitis (n/%) 4 (26.6) 30 (50) NS
Iliopsoas tendinopathy (n/%) 0  8 (13.3) NS
Gluteus medius / minimus tendinopathy (n/%) 7 (9.3) 14 (23.3) NS
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the weight-bearing area, where most of 
the abnormalities appear in OA.
However, to the best of our knowledge, 
the present study represents the first re-
port investigating the role of US in the 
assessment of hip joint in OA, by eval-
uating both articular and periarticular 
involvement as well as inflammatory 
and structural lesions. Further studies 
on larger populations are warranted to 
better define the validity of this imag-
ing tool in this common and complex 
pathology.
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